Comparative trial of SGLT2-inhibitor (Canagliflozin) and sulfonylurea (Glimepiride) for patients with DM
Not Applicable
- Conditions
- Diabetes mellitus type 2
- Registration Number
- JPRN-UMIN000024922
- Lead Sponsor
- Sekino Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were deemed not appropriate to participate in this study by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method somatic fat volume (CT)
- Secondary Outcome Measures
Name Time Method HbA1c Body weight, body fat percentage somatic fat volume (CT) BNP serum Cr,eGFR glycoalbumin U-alb, U-type IV collagen cystatin C, ox-LDL, Lp (a), EPA/AA T-cho,LDL,HDL.TG Bood pressure FMD, ABI, PWV complication